Health House International Limited announced the proposed acquisition of CanPharma GmbH with operations in both Germany and Spain. Subject to approval from Health House shareholders, and all conditions of sale being met, Health House will acquire 100% of CanPharma through an all-scrip transaction. As part of the Acquisition, CanPharma founder Dr. Henrik Sprengel will remain CEO of CanPharma and be appointed as an executive director of Health House. Dr Sprengel is co-founder of both CanPharma and Kalapa Clinic where he has gained extensive experience in the field of medicinal cannabis. Before founding CanPharma, he was CEO of the company builder Grupo HS3, which successfully launched several international projects across a number of industries, with a focus on internet and technology. Henrik started his career as a lawyer at Clifford Chance; he later held several international senior management positions in global media company Bertelsmann.